BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3347139)

  • 1. A redox system for brain targeted estrogen delivery causes chronic body weight decrease in rats.
    Estes KS; Brewster ME; Bodor NS
    Life Sci; 1988; 42(10):1077-84. PubMed ID: 3347139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats.
    Estes KS; Brewster ME; Simpkins JW; Bodor N
    Life Sci; 1987 Mar; 40(13):1327-34. PubMed ID: 3561153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a brain-enhanced chemical delivery system for estradiol on body weight and food intake in intact and ovariectomized rats.
    Simpkins JW; Anderson WR; Dawson R; Bodor N
    Pharm Res; 1989 Jul; 6(7):592-600. PubMed ID: 2798308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol.
    Anderson WR; Simpkins JW; Brewster ME; Bodor N
    Life Sci; 1988; 42(16):1493-502. PubMed ID: 3352462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a brain-enhanced estradiol delivery system on testosterone and androgen-dependent tissues. I. Dose-response and time-course evaluation.
    Rahimy MH; Anderson WR; Brewster ME; Bodor N; Simpkins JW
    Endocrinology; 1991 Aug; 129(2):717-25. PubMed ID: 1855469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose and time-course evaluation of a redox-based estradiol-chemical delivery system for the brain. II. Pharmacodynamic responses.
    Rahimy MH; Simpkins JW; Bodor N
    Pharm Res; 1990 Nov; 7(11):1107-12. PubMed ID: 2293207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic weight loss in lean and obese rats with a brain-enhanced chemical delivery system for estradiol.
    Simpkins JW; Anderson WR; Dawson R; Seth A; Brewster M; Estes KS; Bodor N
    Physiol Behav; 1988; 44(4-5):573-80. PubMed ID: 3237846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inhibition of hypothalamic-pituitary-ovarian axis and body weight gain by brain-directed delivery of estradiol-17 beta in female rats.
    Sarkar DK; Friedman SJ; Yen SS; Frautschy SA
    Neuroendocrinology; 1989 Aug; 50(2):204-10. PubMed ID: 2674763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of plasma testosterone and prostate carcinoma size by a redox-based, brain-targeted estrogen delivery system in the rat.
    Rahimy MH; Bodor N; Simpkins JW
    Prostate; 1993; 23(1):79-90. PubMed ID: 8337187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a brain-enhanced estradiol delivery system on testosterone and androgen-dependent tissues. II. The role of testosterone.
    Anderson WR; Rahimy MH; Brewster ME; Bodor N; Simpkins JW
    Endocrinology; 1991 Aug; 129(2):726-33. PubMed ID: 1855470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a brain-enhanced chemical delivery system for estradiol on body weight and serum hormones in middle-aged male rats.
    Anderson WR; Simpkins JW; Brewster ME; Bodor N
    Endocr Res; 1988; 14(2-3):131-48. PubMed ID: 3168954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the reestablishment of copulatory behavior in castrated male rats with a brain-enhanced estradiol-chemical delivery system.
    Anderson WR; Simpkins JW; Brewster ME; Bodor N
    Pharmacol Biochem Behav; 1987 Jun; 27(2):265-71. PubMed ID: 3628441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose and time-course evaluation of a redox-based estradiol-chemical delivery system for the brain. I. Tissue distribution.
    Rahimy MH; Simpkins JW; Bodor N
    Pharm Res; 1990 Oct; 7(10):1061-7. PubMed ID: 2281037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
    El-Shitany NA; Hegazy S; El-Desoky K
    Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of Estredox, a brain-targeted estradiol delivery system versus traditional estrogen replacement therapy.
    Sziráki I; Horváth K; Bodor N
    Pharmazie; 2006 Feb; 61(2):140-3. PubMed ID: 16526562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat.
    Sibonga JD; Lotinun S; Evans GL; Pribluda VS; Green SJ; Turner RT
    Endocrinology; 2003 Mar; 144(3):785-92. PubMed ID: 12586754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status.
    Moon LY; Wakley GK; Turner RT
    Endocrinology; 1991 Sep; 129(3):1568-74. PubMed ID: 1874188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a 3-substituted versus 17-substituted chemical delivery system for estradiol brain targeting.
    Brewster ME; Druzgala PJ; Anderson WR; Huang MJ; Bodor N; Pop E
    J Pharm Sci; 1995 Jan; 84(1):38-43. PubMed ID: 7714741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the antiestrogen LY 117018 on the modulation by ethinyl estradiol of the metabolism of [1-14C]oleic acid by perfused livers from normal and ovariectomized rats.
    Weinstein I; Heimberg M
    Biochem Pharmacol; 1988 Jan; 37(2):319-26. PubMed ID: 3342088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of chronic testosterone administration on body weight, food intake, and adipose tissue are changed by estrogen treatment in female rats.
    Iwasa T; Matsuzaki T; Yano K; Yanagihara R; Tungalagsuvd A; Munkhzaya M; Mayila Y; Kuwahara A; Irahara M
    Horm Behav; 2017 Jul; 93():53-61. PubMed ID: 28522306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.